Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway Inflammation
Diana C. Contreras(Vanderbilt University Medical Center), Jeffrey C. Rathmell(University of Chicago), Sierra Barone(Vanderbilt University), Valerie A. Gerriets, Jonathan A. Hemler(University of Virginia), Nowrin U. Chowdhury(Islamic University), Masha V. Poyurovsky(Princeton University), Jonathan M. Irish(Vanderbilt University), Kirsten Young, Debolanle O. Dahunsi(Vanderbilt University Medical Center), Ryszard Dworski(Vanderbilt University), Jason W. Locasale(Duke University), Dawn C. Newcomb(Vanderbilt University), Kellen Olszewski(Princeton University), R. Stokes Peebles(VA Tennessee Valley Healthcare System), Xiang Ye(Qilu Hospital of Shandong University), Xuemei Yu(Eon Corporation (United States)), Peter J. Siska(University Hospital Regensburg), Jacqueline Cephus(Vanderbilt University Medical Center), Matthew Z. Madden(Emory University)
Cited by 35
Related Papers
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
|Cell|2012|2k
Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
|The Journal of Immunology|2011|2k
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
|Nature Genetics|2011|1.1k
Glucose Uptake Is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent Pathways
|The Journal of Immunology|2008|836
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
|Journal of Clinical Investigation|2014|717